Nyxoah S.A. (NYXH) Financials

NYXH Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 192.3 million 97.4 million
March 31, 2026 112.3 million 71.0 million
Dec. 31, 2025 139.1 million 81.4 million
Sept. 30, 2025 109.8 million 50.0 million

NYXH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -20.4 million 1.8 million
March 31, 2026 -25.6 million 1.0 million
Dec. 31, 2025 -15.4 million 1.1 million
Sept. 30, 2025 -24.1 million 1.3 million

NYXH Net Income

No data available :(

NYXH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 111.6 million 31.4 million 2.1 million
March 31, 2026 29.8 million 20.1 million 1.7 million
Dec. 31, 2025 56.4 million 18.9 million 1.7 million
Sept. 30, 2025 26.4 million 22.0 million 2.5 million

NYXH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 65.1 million
March 31, 2026 49.5 million
Dec. 31, 2025 47.1 million
Sept. 30, 2025 43.9 million

NYXH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.5 million 10.9 million 17.8 million -
March 31, 2026 833975 10.0 million 19.8 million -
Dec. 31, 2025 24642 12.8 million 14.1 million -
Sept. 30, 2025 26991 15.2 million 14.2 million -

NYXH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 8.8 million 3.5 million
March 31, 2026 8.4 million 5.9 million
Dec. 31, 2025 6.6 million 2.4 million
Sept. 30, 2025 2.3 million 914179

NYXH

Price: $1.11

52 week price:
1.11
6.88

Earnings Per Share: -2.56 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: Belgium

Volume: 11600

Market Capitalization: 136.1 million

Links: